Bilateral Multifocal Central Serous-Like Chorioretinopathy due to MEK Inhibition for Metastatic Cutaneous Melanoma
Newer chemotherapeutic agents target extracellular signaling, including the mitogen-activated protein kinase kinase (MEK) pathway. We present a case of a 54-year-old female who developed bilateral multifocal central serous-like chorioretinopathy shortly after starting MEK inhibition for metastatic c...
Saved in:
Main Authors: | Scott D. Schoenberger, Stephen J. Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Case Reports in Ophthalmological Medicine |
Online Access: | http://dx.doi.org/10.1155/2013/673796 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Central Serous Chorioretinopathy: Multimodal Imaging and Management Options
by: Prashanth G. Iyer, et al.
Published: (2020-01-01) -
Applications of Multimodal Imaging in Central Serous Chorioretinopathy Evaluation
by: Mary Ho, et al.
Published: (2021-01-01) -
Keratoconus with Central Serous Chorioretinopathy: A Rare Combination
by: Anastasia Tsiogka, et al.
Published: (2020-01-01) -
Risk Factors for Persistent or Recurrent Central Serous Chorioretinopathy
by: Jia Yu, et al.
Published: (2019-01-01) -
The Efficacy of Intravitreal Conbercept for Chronic Central Serous Chorioretinopathy
by: Jianbo Mao, et al.
Published: (2019-01-01)